The Umbrex Healthcare Industry Practice has prepared this guide to terminology, acronyms, shorthand, and insider language to help a newcomer to the health payor sector get up to speed rapidly.
Health Plan Structure
Payer, Payor, Health Plan, and Carrier
Payer is the most common spelling in statutes, policy documents, and technical standards. Payor appears frequently in consulting, contracting, and practice-group language. Both refer broadly to the party financing or administering healthcare benefits, but practitioners often use more precise labels when legal responsibility matters.
A health plan is the benefit arrangement or organization administering coverage. A carrier is usually a licensed insurer. A third-party administrator may process claims for a health plan without insuring them. When someone says, “the payer decided,” ask which legal entity, plan sponsor, administrator, or delegated vendor actually made the decision.
Risk-Bearing Entity
The risk-bearing entity is the legal organization responsible for claims risk. In commercial insurance, it is generally the licensed insurer. In Medicare Advantage or Medicaid managed care, it is the contracted plan receiving capitated payments and assuming responsibility for covered services.
This is not always the company name on the member’s identification card. A national brand may operate through several licensed subsidiaries. The distinction determines which entity files rates, maintains statutory capital, signs provider agreements, reports regulatory data, and answers when claims exceed expectations.
Fully Insured
Under a fully insured arrangement, the employer or individual pays a premium to an insurer, and the insurer bears the covered claims risk. State insurance mandates, premium taxes, rate-filing rules, and state medical loss ratio requirements generally apply to the carrier and product.
Practitioners contrast fully insured business with self-funded business because identical-looking identification cards can conceal very different economics and regulatory regimes. A benefit change that is straightforward for one block may be prohibited, mandated, or priced differently for the other.
Self-Funded and ASO
A self-funded plan places the underlying claims risk on the employer or other plan sponsor. The carrier or administrator may provide administrative services only, commonly shortened to ASO, including network access, claims processing, utilization management, and member service.
The administrator earns fees rather than insurance premium for bearing claims risk. Most private employer plans are governed by the Employee Retirement Income Security Act, or ERISA, although governmental and church plans have different treatment. Stop-loss coverage can limit the sponsor’s exposure, but it does not make the member’s plan fully insured.
Third-Party Administrator, or TPA
A third-party administrator performs functions such as enrollment, claims administration, utilization management, or network access without necessarily underwriting the benefit. Some TPAs are independent; others are affiliated with insurers, provider organizations, or benefit platforms.
ASO describes the service arrangement, while TPA describes the administering organization. The terms overlap, but they are not technically identical. When a TPA is involved, practitioners want to know who owns the network, who controls the plan document, who funds claims, and which party has fiduciary or regulatory responsibility.
Specific and Aggregate Stop-Loss
Stop-loss insurance protects a self-funded plan sponsor rather than the individual member. Specific stop-loss reimburses claims above an attachment point for one covered person. Aggregate stop-loss responds when total eligible plan claims exceed a defined corridor for the entire covered population.
Contracts contain important details such as claims bases, run-in and runout periods, exclusions, reimbursement timing, and lasers, which are higher specific attachment points applied to known high-risk individuals. A plan may have paid the member’s claim correctly and still discover that the stop-loss carrier will not reimburse it.
Level-Funded Plan
A level-funded plan is legally structured as self-funded but packages expected claims, administrative fees, and stop-loss premiums into a stable monthly payment. If actual claims are favorable, some arrangements return part of the surplus. If claims are unfavorable, stop-loss protection limits exposure according to the contract.
Level funding is often marketed to smaller employers as a middle ground between fully insured and traditional self-funded coverage. The stable invoice can look like a premium, which causes frequent confusion. The regulatory classification and claims ownership remain the important facts.
HMO, PPO, EPO, and POS
These labels describe network and access structures, although exact rules vary by product:
- Health maintenance organization, or HMO: generally emphasizes coordinated in-network care, often through a primary care physician. Nonemergency out-of-network coverage is commonly limited.
- Preferred provider organization, or PPO: typically permits both in-network and out-of-network care, with greater member cost sharing outside the preferred network.
- Exclusive provider organization, or EPO: generally covers nonemergency services only within the network but may not require primary care referrals.
- Point-of-service, or POS: combines managed-care features with an out-of-network benefit, often at higher member cost.
Do not infer referral rules or out-of-network benefits solely from the label. The benefit document and product filing control. Product names have a regrettable tendency to sound more standardized than they actually are.
Eligibility and Enrollment
Member, Subscriber, and Dependent
A member is any individual enrolled in coverage. The subscriber, sometimes called the policyholder or employee, is the person through whom coverage is established. A dependent receives coverage through the subscriber.
Claims, accumulators, identification numbers, and enrollment records may be stored at either the member or family level. Confusing the subscriber identifier with the individual member identifier is a reliable way to make an otherwise valid transaction disappear into an eligibility queue.
Eligibility Span
An eligibility span is the effective-to-termination date range during which a member is enrolled in a particular product, group, benefit package, and coverage tier. A person can have multiple spans because of job changes, plan elections, reinstatements, or retroactive corrections.
Practitioners rarely ask only whether a person is “eligible.” They ask whether the correct eligibility span was active on the date of service. A claim can be valid clinically and properly coded, yet deny because it hit the wrong span or benefit package.
834 Enrollment Transaction
The ANSI X12 834 is the standard electronic transaction used to transmit enrollment additions, changes, and terminations from an employer, marketplace, government agency, or enrollment platform to a health plan.
An 834 file may contain effective dates, coverage levels, demographic data, maintenance reason codes, and member relationships. Saying “the 834 loaded” means the plan’s enrollment system accepted and applied the transaction, not merely that a file was sent. File acceptance, record acceptance, and correct downstream enrollment are three separate victories.
Retro Term and Reinstatement
A retroactive termination, or retro term, ends coverage effective on a date earlier than the processing date. A reinstatement restores a terminated eligibility span, sometimes with no break and sometimes with corrected dates.
These changes can trigger claim reversals, recoupments, pharmacy reversals, accumulator rebuilding, provider outreach, and member confusion. Regulations and contracts may restrict how far back coverage can be terminated, especially when premiums were paid or the member relied on an eligibility confirmation.
Coordination of Benefits, or COB
Coordination of benefits determines payment order when a person has coverage under more than one health plan. The primary plan adjudicates first; the secondary plan then considers remaining eligible amounts under its COB methodology.
Rules may depend on employment status, dependent status, birthdays, custody arrangements, disability, or Medicare entitlement. The birthday rule generally uses the earlier calendar birthday of the parents, not the older parent. COB is distinct from subrogation, which pursues recovery from a liable third party rather than another health plan.
Member Month
A member month represents one member enrolled for one month. It is the denominator behind many plan metrics, including claims per member per month, or PMPM, utilization rates, and administrative fees.
Membership counts at a point in time and member months over a period answer different questions. A plan with heavy midyear growth may report similar ending membership but materially different member months, which affects virtually every normalized financial comparison.
Benefit Design
Allowed Amount
The allowed amount is the amount a plan recognizes for a covered service before applying member cost sharing. For an in-network claim, it is generally determined by the provider contract. For an out-of-network claim, it may be based on a plan methodology, a reference price, a statutory amount, or another defined schedule.
The allowed amount is not the provider’s billed charge, the plan payment, or the member liability. Those numbers may all differ. Many claims conversations become much easier once everyone states which of the four they are discussing.
Deductible, Copayment, and Coinsurance
A deductible is the amount a member must incur for specified covered services before the plan begins paying under the applicable benefit. A copayment is usually a fixed dollar amount. Coinsurance is a percentage of the allowed amount.
These mechanisms may apply differently by service category, network tier, member, family, or benefit. Some services bypass the deductible; others apply to both deductible and coinsurance. A statement such as “covered at 80 percent” is incomplete until someone identifies which amount is being multiplied and whether the deductible has been met.
Out-of-Pocket Maximum
The out-of-pocket maximum, or OOP max, caps specified member cost sharing for covered services during the benefit period. Once reached, the plan generally pays 100 percent of further covered allowed amounts within the applicable scope.
Premiums, excluded services, noncovered amounts, and certain balance bills ordinarily do not count. Plans may maintain separate in-network and out-of-network limits. The statutory maximum and the plan’s actual maximum are related but not always identical.
Embedded and Aggregate Family Deductibles
With an embedded deductible, an individual family member can satisfy an individual deductible and begin receiving post-deductible benefits before the family as a whole reaches its family deductible. With an aggregate family deductible, the full family amount generally must be met before post-deductible coverage begins for anyone.
The same distinction can apply to out-of-pocket limits. It matters operationally because accumulator systems must know whether to evaluate individual and family thresholds independently or collectively.
Accumulator
An accumulator is the running record of amounts credited toward a deductible, out-of-pocket maximum, visit limit, or other benefit threshold. Plans often maintain separate accumulators by member, family, network level, and benefit category.
Accumulator defects can arise after retroactive eligibility changes, claim reversals, cross-vendor data delays, or pharmacy transactions. When practitioners say “the claim paid correctly but the accumulator is wrong,” they mean today’s payment may look fine while tomorrow’s member liability is being quietly miscalculated.
Benefit Exclusion and Medical Necessity Denial
A benefit exclusion means the plan document does not cover the service or circumstance. A medical necessity denial means the service falls within a potentially covered category but does not satisfy the plan’s clinical criteria in the specific case.
The distinction controls notice language, appeal rights, reviewer qualifications, and available evidence. A cosmetic procedure excluded by the plan is not the same issue as a covered surgery denied because clinical criteria were not met.
EOC, SPD, and SBC
The Evidence of Coverage, or EOC, describes benefits and member rights for many insured and government products. The Summary Plan Description, or SPD, is the ERISA-oriented document describing a self-funded employee benefit plan. The Summary of Benefits and Coverage, or SBC, is a standardized high-level summary designed for comparison.
The SBC is useful, but it is not the complete adjudication rulebook. In disputes, practitioners trace the controlling language through the governing plan document, amendments, certificates, riders, and applicable law.
Reference-Based Pricing
Reference-based pricing sets the plan’s recognized amount using an external benchmark, often a percentage of Medicare reimbursement or another cost-based reference, rather than a conventional negotiated network rate.
The arrangement can reduce plan payments but may expose members to balance billing if providers do not accept the reference amount. Successful programs therefore depend on plan language, member advocacy, provider negotiation, and a defensible pricing methodology, not merely a spreadsheet containing Medicare multiples.
Benefit Carve-Out
A benefit carve-out assigns a category such as pharmacy, behavioral health, dental, transplant, or fertility services to a separate administrator, network, or contractual arrangement. The service remains part of the broader benefit ecosystem but operates through a distinct vendor or platform.
Carve-outs create interface questions around eligibility, authorization, claims routing, accumulators, appeals, and reporting. The member experiences one benefit; the operating model may involve several organizations politely insisting that another one owns the issue.
Claims Adjudication
Claim and Encounter
A claim requests payment or records liability for services. An encounter records a service even when no separate payment is due, commonly because the provider is capitated or otherwise prepaid.
Encounters remain essential for risk adjustment, quality measurement, utilization analysis, regulatory reporting, and rate setting. “No claim payment” does not mean “no data obligation.” Government programs can impose significant consequences when encounter data is missing or rejected.
837P, 837I, and 837D
The ANSI X12 837 family carries electronic healthcare claims. 837P supports professional claims, 837I institutional claims, and 837D dental claims. Their paper counterparts include the CMS-1500 and UB-04 forms.
The formats differ in provider roles, service lines, diagnosis and procedure fields, facility details, and payment logic. A hospital outpatient claim and a physician claim for the same visit may travel through different 837 formats and adjudication pathways.
Clean Claim
A clean claim contains the information required for adjudication and does not require external investigation or correction. Prompt-payment laws and provider agreements often establish deadlines measured from receipt of a clean claim.
“Clean” does not mean payable. A complete claim can adjudicate to a valid denial. Conversely, an incomplete claim may be rejected before the plan reaches coverage or medical necessity.
Claim Adjudication
Adjudication is the rule-driven process that determines whether a claim is eligible, covered, priced, payable, denied, or routed for further review. Typical stages include member matching, provider matching, benefit evaluation, authorization checks, coding edits, pricing, coordination of benefits, and cost-sharing calculation.
The word sounds like one decision. Operationally, it is a sequence of dependent system decisions. Finding the stage at which the result diverged is usually more useful than saying, “the system denied it.”
Rejected, Pended, and Denied
A rejected claim generally failed intake or validation and was not fully adjudicated. A pended claim has paused for information, manual review, or another dependency. A denied claim completed adjudication but produced no payment for one or more lines.
These statuses drive different next steps. A rejection may require resubmission, a pend may require records or internal action, and a denial may carry formal appeal rights. Calling every unpaid claim a denial obscures both the cause and the available remedy.
Claim Edit and NCCI
A claim edit is a rule that evaluates coding, billing, coverage, duplication, frequency, provider type, or other conditions. The National Correct Coding Initiative, or NCCI, includes procedure-to-procedure and medically unlikely edits used to identify coding combinations or units that should not ordinarily be paid as submitted.
Plans may apply NCCI logic alongside proprietary edits and contract-specific rules. An edit identifies a billing condition; it is not automatically an accusation of fraud. Modifiers can override some edits when documentation supports the exception.
EOB and ERA
An Explanation of Benefits, or EOB, is the member-facing explanation of how a claim was processed. An Electronic Remittance Advice, or ERA, is the provider-facing electronic remittance, generally transmitted through the X12 835 transaction.
Neither is a provider invoice. Both show elements such as billed amount, allowed amount, plan payment, member responsibility, and adjustment reasons, but they serve different recipients and workflows.
CARC and RARC
Claim Adjustment Reason Codes, or CARCs, identify why an amount was adjusted. Remittance Advice Remark Codes, or RARCs, provide additional explanation. They appear on remittance transactions and are central to provider payment posting and denial management.
A CARC may state the financial category of an adjustment, while a RARC explains the missing authorization, filing issue, coding condition, or policy detail. Practitioners reviewing denial patterns usually need both.
Corrected Claim, Reconsideration, and Appeal
A corrected claim replaces or changes previously submitted claim data. A reconsideration asks the payer to reprocess or reevaluate an adjudication, often because existing information was overlooked. An appeal challenges a coverage, payment, or medical necessity determination through a defined review process.
Submitting the wrong vehicle can reset nothing and consume valuable filing time. If the diagnosis code was wrong, use the correction path. If the data were right but the decision was wrong, reconsideration or appeal is usually the relevant path.
Subrogation and Third-Party Liability
Subrogation allows a plan to recover payments from a party legally responsible for an injury or loss, such as an automobile insurer or tort defendant. In Medicaid, the broader term third-party liability, or TPL, covers other legally liable coverage that should pay before Medicaid.
Subrogation differs from coordination of benefits because the other payer is not necessarily another health plan. Accident indicators, diagnosis codes, and member questionnaires commonly trigger the recovery workflow.
Provider Networks and Reimbursement
NPI, TIN, and Provider Hierarchy
The National Provider Identifier, or NPI, identifies healthcare providers in standard transactions. The Taxpayer Identification Number, or TIN, identifies the tax entity receiving payment. Claims can also distinguish billing, rendering, referring, attending, and service-facility providers.
Network participation may be contracted at one level and loaded at another. A provider can be credentialed yet price as out of network because the correct NPI, TIN, location, specialty, or effective date was not associated with the contract.
Credentialing and Delegated Credentialing
Credentialing verifies that a practitioner or facility meets defined participation standards, including licensure, education, sanctions, insurance, and professional history. Recredentialing repeats the review at prescribed intervals.
Under delegated credentialing, a health plan permits another organization, often a large provider group, to perform specified credentialing functions. The plan retains oversight and commonly audits files, policies, committee records, and roster controls. Delegation transfers work, not accountability.
Network Adequacy and Directory Accuracy
Network adequacy evaluates whether a plan has sufficient provider capacity and geographic access for covered populations. Regulators may apply time-and-distance standards, appointment wait times, provider-to-member ratios, specialty requirements, and exception processes.
Directory accuracy asks whether listed providers are actually reachable, accepting members, practicing at the stated location, and participating in the relevant product. A ghost network is a directory that appears adequate on paper but contains unavailable or inaccurate listings.
Fee Schedule, RVU, and RBRVS
A fee schedule assigns payment amounts to covered services. Many professional fee schedules use relative value units, or RVUs, under a resource-based relative value scale, or RBRVS. RVUs generally reflect physician work, practice expense, and malpractice components, adjusted geographically and multiplied by a conversion factor.
A contract stating “120 percent of Medicare” still requires details about the Medicare year, locality, code status, modifiers, and updates. The percentage is the simple part.
Diagnosis-Related Group, or DRG
A DRG groups an inpatient hospital stay into a payment category using diagnoses, procedures, discharge status, demographics, and other clinical factors. Payment is commonly based on a DRG weight multiplied by a base rate, with possible adjustments for outliers, transfers, teaching status, or other contract terms.
DRG payment is case-based rather than a separate payment for every billed service. Changes in principal diagnosis, complications, or procedure coding can materially change the assigned DRG and reimbursement.
Ambulatory Payment Classification, or APC
APCs are Medicare’s primary grouping mechanism for many hospital outpatient services. Services are grouped according to clinical and resource similarity, with packaging rules determining which items receive separate payment.
Commercial contracts may adopt or modify APC logic. APCs should not be confused with DRGs: DRGs generally classify inpatient stays, while APCs generally classify outpatient facility services.
Per Diem and Case Rate
A per diem pays a defined amount for each covered day, often varying by unit or level of care. A case rate pays a fixed amount for an episode, procedure, or admission regardless of the precise number of services within the defined bundle.
Both require careful definitions of included services, exclusions, implants, stop-loss provisions, transfer rules, and readmissions. The rate itself rarely causes the argument; the definition of what the rate includes does.
Capitation
Capitation is a prospective payment, usually expressed as PMPM, for responsibility over a defined population and service set. Professional capitation may cover physician services, while global capitation can include a much broader range of medical costs.
Important terms include eligibility attribution, covered services, risk adjustment, carve-outs, stop-loss protection, encounter submission, and reconciliation. Capitation shifts utilization risk, but the amount of risk depends entirely on the contractual perimeter.
Shared Savings and Downside Risk
A shared-savings arrangement compares actual spending for an attributed population with a benchmark, then allocates qualifying savings if quality and contractual conditions are met. Downside risk requires the provider organization to repay or absorb some portion of excess spending.
A one-sided arrangement offers upside only. A two-sided arrangement includes both savings and losses. Benchmark construction, trend, risk adjustment, attribution, exclusions, and minimum savings or loss rates can matter more than the headline sharing percentage.
Single-Case Agreement and Letter of Agreement
A single-case agreement, or SCA, establishes terms for one member or episode when no suitable in-network arrangement exists. A letter of agreement, or LOA, similarly documents negotiated terms for a limited service, case, or time period.
Organizations use the labels differently, but both are narrower than a full provider contract. They must specify services, dates, rates, authorization conditions, billing rules, and whether the arrangement changes the member’s network cost sharing.
Narrow, Tiered, and Wrap Networks
A narrow network intentionally limits participating providers. A tiered network places providers into benefit tiers with different member cost sharing. A wrap network supplements the primary network in geographies or specialties where direct coverage is limited.
A rental or wrap-network claim may price under a third party’s agreement rather than the plan’s direct contract. Practitioners therefore ask which network logo, contract hierarchy, and pricing source applied, not merely whether the provider was “in network.”
Network Leakage
Network leakage is utilization that occurs outside a preferred, owned, or contractually targeted provider network. Health plans and integrated delivery systems monitor it because out-of-network or nonpreferred care may increase cost, disrupt care coordination, or weaken value-based performance.
Leakage can reflect inadequate capacity, weak referral patterns, inaccurate directories, member preference, or clinical necessity. A high leakage rate is not automatically a steerage problem; sometimes the preferred network simply lacks the required service.
Utilization Management
Medical Necessity
Medical necessity is the plan-defined standard used to determine whether a service is clinically appropriate under the member’s benefit and the circumstances presented. Definitions typically consider diagnosis, evidence, setting, frequency, accepted standards, and whether a less intensive alternative is appropriate.
A service can be medically beneficial yet fail the plan’s medical necessity criteria. It can also be medically necessary but excluded from coverage. Clinical merit, benefit coverage, and payment eligibility are related questions, not interchangeable ones.
Prior Authorization and Precertification
Prior authorization, or PA, requires approval before specified services, drugs, procedures, or admissions. Precertification is often used similarly, particularly for facility services, although terminology varies by plan.
Authorization confirms that submitted information satisfies designated requirements at that time. It is generally not a guarantee of payment. Eligibility, coding, network status, benefit limits, and claim submission must still be correct.
MCG and InterQual
MCG and InterQual are proprietary clinical criteria sets used in utilization management. They support decisions about level of care, length of stay, procedures, post-acute services, and other treatment questions.
They inform rather than replace clinical judgment and plan language. A reviewer may apply a licensed criteria set, a government coverage rule, a plan policy, or specialist judgment depending on the product and service.
Concurrent Review
Concurrent review evaluates an ongoing admission or course of treatment while care is being delivered. Reviewers assess continued stay, level of care, discharge planning, clinical milestones, and whether additional days or services meet criteria.
In an inpatient review meeting, “we are out of authorized days” usually means the current authorization period has ended, not necessarily that the patient must be discharged. It signals that further clinical information or a new determination is required.
Retrospective Review
Retrospective review occurs after services have been delivered. It may evaluate medical necessity, coding, authorization compliance, or payment accuracy when prospective or concurrent review did not occur or when later information raises a question.
Retrospective review has different practical stakes because the care cannot be redirected. Notice rules, provider liability, member protection, and appeal rights become especially important.
Level of Care and Patient Status
Level of care identifies the intensity and setting appropriate to the patient, such as acute inpatient, observation, skilled nursing, inpatient rehabilitation, or home health. Patient status is the formal classification under which a facility reports and bills the stay.
Observation and inpatient care can occur in the same hospital bed but follow different coverage and reimbursement rules. The distinction affects authorization, member cost sharing, DRG eligibility, and post-acute coverage.
Peer-to-Peer Review
A peer-to-peer review, often shortened to P2P, is a discussion between the treating clinician and a plan medical director or other qualified reviewer concerning a proposed or denied service.
A P2P can clarify missing clinical facts or criteria application, but it may not replace a formal appeal. Deadlines matter. When a team says “offer P2P,” someone should immediately ask whether the appeal clock continues running.
Adverse Benefit Determination
An adverse benefit determination is a formal denial, reduction, termination, or failure to provide or pay a benefit based on eligibility, coverage, medical necessity, experimental status, or another plan ground.
The classification triggers notice content, timing standards, reviewer requirements, and appeal rights. Not every claim adjustment is an adverse benefit determination, but treating one casually can create regulatory exposure.
Appeal, Grievance, and External Review
An appeal challenges an adverse benefit determination. A grievance generally concerns service, access, conduct, quality, or administration rather than a specific adverse benefit decision. External review sends an eligible dispute to an independent review organization after applicable internal steps.
Definitions and timelines vary across ERISA, state-regulated, Medicare, Medicaid, and marketplace products. The member’s product determines the pathway, not the vocabulary someone happens to use on the phone.
Site-of-Care Management
Site-of-care management directs clinically appropriate services toward settings with different cost and operational profiles, such as moving an infusion from a hospital outpatient department to a physician office, ambulatory center, or home.
The decision involves clinical suitability, network availability, drug sourcing, member access, and benefit rules. Calling it a simple location change understates the number of authorizations, contracts, and delivery arrangements that may need to change with it.
Gold Carding
Gold carding exempts qualifying providers from some prior authorization requirements based on approval history, performance, or statutory criteria. Several states impose gold-card rules, while plans may also operate voluntary programs.
The exemption may apply only to specified services, provider identifiers, specialties, products, or time periods. It is not necessarily transferable across a group’s TIN or every location where the clinician practices.
Quality and Population Health
HEDIS
The Healthcare Effectiveness Data and Information Set, or HEDIS, is a widely used set of standardized health plan performance measures maintained by the National Committee for Quality Assurance, or NCQA. Measures address preventive care, chronic conditions, access, utilization, and treatment outcomes.
A HEDIS rate has a technical specification governing eligibility, denominator, numerator, exclusions, data sources, and timing. A clinically sensible shortcut may still be invalid if it does not satisfy the specification.
Measurement Year and Reporting Year
The measurement year is the period in which qualifying enrollment, services, or outcomes occur. The reporting year is when results are submitted or published. The two are commonly offset.
This distinction matters when measures change. A team discussing “2026 results” may mean services delivered in 2025, data submitted in 2026, or ratings applied to a later payment year. Ask which clock is running.
Administrative, Hybrid, and ECDS Measures
An administrative measure relies primarily on claims, encounters, enrollment, and other structured data. A hybrid measure supplements administrative data with medical-record review for a sample. The Electronic Clinical Data Systems, or ECDS, approach uses standardized electronic clinical sources across the eligible population.
The collection method affects staffing, auditability, timeliness, and improvement strategy. A gap invisible in claims may be closed through clinical data, but only if the source and code satisfy the measure specification.
Care Gap
A care gap is the absence of evidence that a member has received a recommended service or achieved a measure requirement. Examples include a missing screening, immunization, follow-up visit, or controlled clinical result.
A care gap is often a data statement rather than a definitive clinical statement. The service may have occurred but not reached the plan through a usable claim, encounter, lab feed, registry, or chart record.
Medicare Star Ratings
Medicare Star Ratings evaluate Medicare Advantage and Part D contracts across clinical quality, member experience, access, complaints, and operational performance. Ratings affect market perception, enrollment, quality bonus payments, and rebate economics.
Measures use different data periods and may be subject to cut points, weighting rules, and contract-level aggregation. “Moving one Star” is not a single operational initiative. It is a portfolio of measure-specific changes whose financial effect may appear years after the underlying care.
CAHPS and HOS
The Consumer Assessment of Healthcare Providers and Systems, or CAHPS, captures member-reported experience such as access, communication, and plan service. The Health Outcomes Survey, or HOS, measures health status and functional outcomes among Medicare Advantage members.
These are not satisfaction polls casually created by the plan. Sampling, survey administration, case mix, response patterns, and CMS specifications influence the reported results.
NCQA Accreditation
NCQA accreditation evaluates health plans against standards covering quality management, population health, network management, utilization management, credentialing, member rights, and related functions.
Accreditation evidence often includes policies, files, committee records, reports, and proof that processes operate as written. A beautifully drafted policy with no operational evidence is, in accreditation terms, mostly decorative.
Risk Stratification and Health Risk Assessment
Risk stratification groups members according to predicted clinical need, utilization, or avoidable cost using claims, pharmacy, demographic, laboratory, and social data. A health risk assessment, or HRA, collects member-reported information to identify needs not visible in administrative data.
Stratification determines who is offered case management, outreach, home assessment, or other interventions. It is not the same as regulatory risk adjustment, which modifies revenue or payment based on expected cost.
Attribution
Attribution assigns members to a provider, practice, accountable care organization, or other clinical entity for measurement and financial accountability. Methods may use primary care selection, plurality of visits, claims history, or prospective assignment.
The attribution rule determines whose quality and cost results include the member. Two organizations can analyze the same population and produce different performance simply because their attribution windows or hierarchies differ.
Pharmacy Benefit Management
Pharmacy Benefit Manager, or PBM
A PBM administers pharmacy benefits through functions such as claims processing, formulary management, pharmacy network contracting, utilization management, rebate negotiation, and specialty pharmacy services.
The PBM may operate under a traditional spread arrangement, an administrative-fee model, or a more customized contract. Understanding the economics requires tracing member cost sharing, pharmacy reimbursement, manufacturer payments, guarantees, and retained fees separately.
Formulary and Tiering
A formulary is the list of drugs covered under the pharmacy benefit, together with clinical and utilization conditions. Tiering assigns different member cost-sharing levels, commonly distinguishing preferred generics, preferred brands, nonpreferred drugs, and specialty products.
Formulary status affects member access, manufacturer contracting, prescriber behavior, and plan cost. “Covered” may still mean nonpreferred, subject to prior authorization, or available only after another therapy fails.
Pharmacy and Therapeutics Committee
The Pharmacy and Therapeutics Committee, or P&T Committee, evaluates medications for formulary placement using evidence on safety, efficacy, clinical role, and therapeutic alternatives. Financial analysis is typically separated from the formal clinical assessment under applicable governance rules.
The committee may recommend exclusions, preferred status, utilization controls, or class treatment. A commercially attractive rebate does not by itself make a drug clinically preferred.
Step Therapy, Quantity Limit, and Drug PA
Step therapy requires use or failure of designated alternatives before coverage of another drug. A quantity limit restricts the amount covered over a period. A drug prior authorization requires clinical or administrative approval before dispensing.
These controls operate at the point of sale and can generate immediate pharmacy rejects. Exceptions, continuation-of-therapy rules, emergency supplies, and state-specific restrictions are operationally important.
Manufacturer Rebate
A manufacturer rebate is a payment associated with formulary access, market share, utilization, or other contractual conditions. Rebates are usually reconciled after claims occur and may be retained, passed through, or credited according to the PBM and plan contract.
The rebate is distinct from the amount paid at the pharmacy counter. A high-rebate drug can have a low net plan cost but still create high member cost sharing if the benefit calculates coinsurance from a pre-rebate amount.
Spread Pricing and Pass-Through
Under spread pricing, the PBM charges the plan more for a prescription than it reimburses the pharmacy and retains the difference. Under a pass-through model, pharmacy reimbursement and other financial flows are passed to the plan, usually in exchange for explicit administrative fees.
Contracts define these terms differently, so labels alone are unreliable. Rebate retention, network fees, guarantees, specialty economics, and affiliated-pharmacy profits can remain relevant even in a nominally pass-through arrangement.
Maximum Allowable Cost, or MAC
A MAC list establishes maximum reimbursement amounts for specified multisource generic drugs. PBMs use MAC pricing to manage pharmacy reimbursement when multiple equivalent products are available.
Pharmacies care about list updates, acquisition-cost alignment, appeal rights, and effective dates. Plans care about whether MAC savings are passed through. There can be multiple MAC lists in the same arrangement, which is rarely the cheerful discovery it sounds like.
AWP, WAC, and NADAC
Average Wholesale Price, or AWP, is a published benchmark commonly used in pharmacy contracting but is not an average transaction price. Wholesale Acquisition Cost, or WAC, is a manufacturer’s list price to wholesalers before many discounts. National Average Drug Acquisition Cost, or NADAC, estimates pharmacy acquisition cost using survey data.
Each answers a different pricing question. A contract expressed as “AWP minus” cannot be compared directly with a NADAC-based arrangement without considering dispensing fees, rebates, product mix, and benchmark updates.
Specialty Drug and Limited Distribution
Specialty drugs generally involve high cost, complex administration, special handling, intensive monitoring, or treatment of serious and uncommon conditions. A limited-distribution drug is available only through selected pharmacies or channels designated by the manufacturer.
Specialty management spans pharmacy and medical benefits, provider administration, site of care, adherence, and manufacturer access rules. “Move it to the preferred specialty pharmacy” may not be possible when distribution is contractually restricted.
Medical Benefit and Pharmacy Benefit
Self-administered outpatient drugs are commonly processed through the pharmacy benefit using National Drug Codes. Clinician-administered drugs may be billed through the medical benefit using HCPCS codes, often under a buy-and-bill model in which the provider purchases and administers the drug.
The same active ingredient can follow different authorization, pricing, rebate, and cost-sharing pathways depending on setting and formulation. Cross-benefit visibility is therefore crucial for specialty-drug management.
White, Brown, and Clear Bagging
White bagging sends a patient-specific drug from a specialty pharmacy to the administering provider. Brown bagging sends the drug to the patient, who transports it to the provider. Clear bagging generally uses a health-system-owned specialty pharmacy to supply the system’s administering site.
These models affect drug ownership, storage, scheduling, waste, reimbursement, and clinical responsibility. Brown bagging raises particular chain-of-custody and handling concerns and is restricted in some settings.
Copay Accumulator and Maximizer
A copay accumulator program prevents manufacturer assistance from counting toward the member’s deductible or out-of-pocket maximum. A copay maximizer restructures cost sharing to capture available assistance across the benefit year, often classifying selected drugs under a special program.
The programs have materially different member and accounting effects and are subject to evolving legal rules. Both require precise coordination among the plan, PBM, specialty pharmacy, and assistance program.
Risk Adjustment
Risk Adjustment
Risk adjustment modifies plan revenue, premiums, benchmarks, or transfers to reflect expected healthcare cost based on member characteristics. It is intended to reduce incentives to avoid high-risk populations and to improve comparability among plans.
Medicare Advantage, the ACA individual and small-group markets, and Medicaid use different models and payment mechanics. A “risk score” is therefore meaningless without identifying the program, model version, data year, and population.
Hierarchical Condition Category, or HCC
An HCC groups diagnosis codes into clinically related categories used in risk-adjustment models. Hierarchies prevent related conditions of differing severity from being counted independently when the model intends only the most severe category to apply.
CMS-HCC models support Medicare Advantage risk adjustment, while HHS-HCC models support ACA market transfers. They share a name but differ in diagnoses, populations, timing, coefficients, and payment purpose.
Risk Adjustment Factor, or RAF
A risk adjustment factor, commonly called a RAF score, summarizes predicted relative cost under a specified model. Demographic factors and accepted condition categories contribute coefficients to the score.
A RAF of 1.0 generally represents the model’s reference level, but comparisons across model years or populations can mislead. Normalization, coding-pattern adjustments, model recalibration, and member mix can move revenue without any change in clinical reality.
Prospective and Concurrent Models
A prospective model uses diagnoses from one period to predict costs in a later period. Medicare Advantage risk adjustment is largely prospective. A concurrent model uses diagnoses from the same period as the costs being explained, as in the ACA risk-adjustment framework.
The distinction changes documentation timing and operational strategy. A diagnosis captured after the relevant data period may be clinically valid but financially irrelevant to that payment year.
Suspecting and Chart Chase
Suspecting uses claims, medications, laboratory results, prior diagnoses, and analytics to identify conditions that may exist but lack current compliant documentation. A chart chase retrieves medical records to validate reported diagnoses or identify supported coding opportunities.
A suspect is not a diagnosis. Coding requires a qualifying encounter and documentation from an appropriate provider. Treating analytic likelihood as clinical proof creates audit and compliance risk.
Coding Intensity
Coding intensity describes how completely or aggressively diagnoses are documented and submitted relative to underlying morbidity. Differences can arise from care models, documentation practices, chart review, home assessments, and data capture.
Higher coding intensity may reflect more complete records, but it does not automatically mean the population became sicker. Regulators examine whether submitted conditions are supported and whether coding patterns exceed expected differences.
RAPS, EDPS, and Encounter Submission
Medicare Advantage plans historically submitted risk-adjustment data through the Risk Adjustment Processing System, or RAPS. CMS increasingly relies on the Encounter Data Processing System, or EDPS, which evaluates more detailed encounter records.
Acceptance by a clearinghouse does not mean acceptance by EDPS, and EDPS acceptance does not necessarily mean a diagnosis is eligible for risk adjustment. Submission, acceptance, filtering, and payment are distinct stages.
RADV
Risk Adjustment Data Validation, or RADV, audits whether diagnoses used for Medicare Advantage payment are supported by medical records and meet applicable coding and documentation rules.
Unsupported diagnoses can produce repayment obligations, and sampling or extrapolation can magnify the financial effect. RADV turns what looked like a coding workflow into a material revenue-recoupment question.
Medicare Advantage and Part D
Original Medicare and Medicare Advantage
Original Medicare delivers Part A and Part B coverage directly through the federal program. Medicare Advantage, or MA and formally Medicare Part C, delivers Medicare-covered benefits through private plans under contract with CMS.
MA plans receive risk-adjusted payments and may offer supplemental benefits, network structures, and utilization controls. They must cover Medicare benefits but do not simply replicate Original Medicare’s administration.
PDP and MA-PD
A Prescription Drug Plan, or PDP, provides standalone Medicare Part D coverage. An MA-PD plan combines Medicare Advantage medical coverage with Part D prescription coverage.
The distinction affects enrollment, bidding, Stars, benefit design, and member communications. A Medicare Advantage plan without drug coverage is not automatically incomplete; certain product types or member circumstances permit separate arrangements.
Bid, Benchmark, and Rebate
An MA plan submits a bid representing expected cost for providing Medicare-covered Part A and Part B services to an average-risk member. CMS compares the bid with a county-level benchmark.
If the bid is below the benchmark, a portion of the difference becomes a rebate that funds supplemental benefits, reduced cost sharing, or premium reductions. If the bid exceeds the benchmark, members generally pay an additional premium. Risk adjustment then modifies payment for actual member mix.
Special Needs Plan, or SNP
A Special Needs Plan is an MA plan designed for a defined population. A D-SNP serves people eligible for both Medicare and Medicaid. A C-SNP serves people with qualifying chronic conditions. An I-SNP serves institutionalized or institutional-equivalent populations.
SNPs have specialized care models, eligibility requirements, and coordination obligations. “Dual plan” usually means D-SNP, but practitioners still need to know the state Medicaid arrangement and level of integration.
Dual Eligible and LIS
A dual eligible beneficiary qualifies for both Medicare and Medicaid, although the extent of Medicaid benefits varies. The Low-Income Subsidy, or LIS and commonly called Extra Help, reduces Part D premiums and cost sharing for qualifying beneficiaries.
Dual status, LIS status, and Medicaid eligibility are related but not interchangeable. Changes can affect premiums, cost sharing, enrollment rights, and plan revenue.
Maximum Out-of-Pocket, or MOOP
In Medicare Advantage, MOOP is the annual limit on member cost sharing for Part A and Part B services covered by the plan. CMS establishes maximum parameters, while plans may offer lower limits.
Part D drug spending follows separate rules and does not simply accumulate into the medical MOOP. Combined products therefore maintain distinct medical and pharmacy accounting structures.
TrOOP and Medicare Prescription Payment Plan
True out-of-pocket costs, or TrOOP, are the amounts that count toward the Part D annual out-of-pocket threshold. Certain payments by the member and qualifying third parties count; other payments do not.
The Medicare Prescription Payment Plan, often abbreviated M3P, allows Part D enrollees to spread out-of-pocket prescription costs across monthly payments during the plan year. It changes payment timing, not the underlying covered-drug price or total cost-sharing obligation.
Medicaid Managed Care
Medicaid MCO
A Medicaid managed care organization, or MCO, contracts with a state to provide defined Medicaid benefits for enrolled populations, generally in exchange for capitated payments.
The state remains the program authority, while the MCO administers networks, claims, utilization, quality, and member services under federal and state requirements. Medicaid rules vary significantly by state, so “our Medicaid product” is rarely specific enough for an operating discussion.
Rate Cell
A rate cell is a category used to assign Medicaid capitation rates based on characteristics such as age, eligibility group, region, program status, or institutional level of care. Members in different cells generate different monthly payments.
Eligibility or demographic errors can therefore affect both coverage and revenue. Rate-cell reconciliation is a specialized intersection of enrollment data, state files, and actuarial payment.
Section 1115 Waiver
A Section 1115 demonstration allows CMS to approve experimental or pilot Medicaid approaches that further program objectives. States use 1115 authority for coverage expansions, delivery-system reforms, behavioral health initiatives, work-support programs, and other demonstrations.
The waiver’s special terms and conditions define what is permitted, which populations are included, and how budget neutrality is measured. Calling something “an 1115 program” does not identify the actual benefit or operating rule.
Section 1915(b) and 1915(c) Waivers
A 1915(b) waiver permits certain managed-care arrangements and restrictions on provider choice. A 1915(c) waiver supports home and community-based services for people who would otherwise require institutional care.
States may combine waiver authorities, but the authorities serve different purposes. The distinction affects eligibility, benefits, network obligations, care planning, and federal approval.
HCBS and LTSS
Home and community-based services, or HCBS, help individuals receive care outside institutional settings. Long-term services and supports, or LTSS, include personal care, habilitation, nursing-facility care, and other ongoing supports for functional needs.
Managed LTSS programs combine medical, behavioral, social, and functional-service workflows. Authorization depends not only on diagnosis but also on functional assessment, care plans, setting, and state-specific eligibility criteria.
State Directed Payment
A state directed payment requires or permits Medicaid MCOs to make specified provider payments under a CMS-approved arrangement. Structures can include uniform increases, value-based payments, or payments tied to state-defined delivery-system goals.
These payments sit within managed-care rate and contract mechanics but may not behave like ordinary negotiated reimbursement. Plans must track eligibility, provider classes, payment timing, encounter treatment, and reconciliation requirements.
Redetermination and Churn
Redetermination is the periodic review of Medicaid eligibility. Churn describes members losing and regaining coverage over relatively short periods, sometimes because of administrative barriers rather than a lasting eligibility change.
Churn disrupts care, enrollment spans, capitation, quality measurement, and member outreach. A decline in Medicaid membership may reflect eligibility policy and renewal processing rather than competitive loss.
EPSDT
Early and Periodic Screening, Diagnostic and Treatment, or EPSDT, is Medicaid’s comprehensive benefit for eligible children and adolescents. It requires screening and coverage of medically necessary treatment to correct or ameliorate identified conditions, subject to federal rules.
EPSDT can require broader coverage than a state’s standard adult benefit. Applying adult benefit logic to a pediatric Medicaid request is therefore a significant error, not a small configuration issue.
ACA Marketplace
Qualified Health Plan, or QHP
A Qualified Health Plan is certified for sale through an Affordable Care Act marketplace and must satisfy applicable requirements concerning benefits, network, accreditation, rates, reporting, and consumer protections.
Not every ACA-compliant individual-market plan is sold on an exchange, and only marketplace enrollment can generally access federal premium tax credits. Practitioners therefore distinguish QHP, on-exchange, and off-exchange status.
Metal Level and Actuarial Value
Bronze, Silver, Gold, and Platinum metal levels categorize plans by actuarial value, or AV, which estimates the percentage of covered essential-health-benefit costs paid by the plan for a standard population.
AV is not the percentage paid for every service or member. A Silver plan may have low copays for some services and substantial cost sharing for others while meeting the overall AV target.
APTC and CSR
The advance premium tax credit, or APTC, reduces monthly marketplace premiums for eligible individuals. Cost-sharing reductions, or CSR, reduce deductibles, copayments, coinsurance, and out-of-pocket limits for qualifying enrollees who select eligible Silver-plan variants.
APTC affects premium liability. CSR changes the benefit design. Loading the correct base Silver product with the wrong CSR variant can produce extensive accumulator and claim corrections.
Essential Health Benefits
Essential health benefits, or EHB, are the federally defined benefit categories that most individual and small-group ACA plans must cover, as implemented through state benchmark plans and related rules.
EHB status also affects annual and lifetime dollar-limit restrictions and cost-sharing treatment. The category is federal, but the detailed covered services can vary by state benchmark.
Open Enrollment and Special Enrollment Period
Open enrollment is the annual period when eligible consumers may select marketplace coverage without a separate qualifying event. A special enrollment period, or SEP, permits enrollment following events such as loss of coverage, marriage, birth, or other qualifying circumstances.
SEP verification, effective-date rules, and documentation affect both access and adverse-selection exposure. Enrollment timing is therefore a regulated eligibility mechanism, not simply a sales calendar.
ACA Risk Transfer
The ACA risk-adjustment program transfers funds among individual and small-group market plans based on relative actuarial risk within a market. It is designed to compensate plans enrolling populations with higher expected costs.
The transfer is not a direct reimbursement of a plan’s actual claims. Results depend on HHS-HCC risk scores, premiums, plan factors, market averages, enrollment, and statewide relative position. A plan can improve its own coding and still owe a transfer if the market changes more.
Actuarial and Plan Economics
PMPM and PEPM
Per member per month, or PMPM, normalizes claims, revenue, or fees across member months. Per employee per month, or PEPM, is commonly used for employer-group administrative fees and uses enrolled employees rather than all covered dependents as the denominator.
Confusing PMPM and PEPM can materially distort comparisons because one employee contract may cover several members. Always ask which population, time period, and cost categories are included.
Paid Claims and Incurred Claims
Paid claims are measured when payment is issued. Incurred claims are assigned to the period in which services occurred, regardless of when claims were paid.
Paid data are observable but lag clinical activity. Incurred estimates provide a better view of the service period but require reserves for incomplete claims. A sudden paid-claims decline near year-end may simply mean the claims shop has not finished paying December.
IBNR
Incurred but not reported, or IBNR, estimates claim liability for services already delivered but not yet received or fully recorded. Practitioners often use the term broadly to include received-but-not-paid amounts and other completion adjustments, although accounting definitions may separate them.
IBNR depends on historical payment patterns, recent utilization, operational disruptions, membership changes, and large claims. It is an estimate of missing liability, not an unallocated rainy-day fund.
Claim Lag and Completion Factor
Claim lag is the time between date of service and claim payment or reporting. A completion factor estimates what proportion of ultimate incurred claims is already visible at a particular maturity.
If three-month completion is 90 percent, observed claims are divided by 0.90 to estimate ultimate claims, subject to the actuarial method. Changes in provider submission, adjudication speed, or system migrations can invalidate historical patterns.
Medical Trend
Medical trend is the expected rate of change in healthcare claim cost over time. It reflects unit-price changes, utilization, treatment intensity, technology, provider mix, drug mix, and other factors.
Trend is not general inflation, and it is not a single universal percentage. Inpatient, outpatient, professional, and pharmacy trends can move differently. Pricing a plan with “the trend” invites the obvious follow-up: which trend, on what basis, for which population?
Utilization, Unit Cost, Mix, and Intensity
Health plan cost changes are often decomposed into utilization, the number of services; unit cost, the allowed cost per service; mix, the distribution across service types or providers; and intensity, the complexity or resource level within a service category.
An admission rate can remain flat while inpatient cost rises because cases shifted toward higher-weight DRGs. Saying “utilization is stable” therefore does not settle the cost question.
Credibility
Credibility describes the statistical reliability assigned to a population’s own experience. Larger, more stable populations receive more weight; smaller or volatile groups require blending with manual rates, broader experience, or other benchmarks.
Credibility is not a judgment about whether the data are honest. It asks how much confidence the actuary should place in observed experience as a predictor of future cost.
Medical Loss Ratio
The medical loss ratio, or MLR, compares defined medical claims and quality-improvement expenses with premium revenue after specified adjustments. Federal commercial-market rules and Medicare Advantage rules use program-specific calculations and thresholds.
MLR is not identical to an internal claims loss ratio. Taxes, credibility adjustments, quality expenses, reinsurance, and regulatory definitions can create meaningful differences between the two.
Risk-Based Capital
Risk-based capital, or RBC, is a statutory framework that compares an insurer’s adjusted capital with capital requirements based on underwriting, asset, credit, and other risks. Regulators use RBC ratios to identify levels of financial concern and potential intervention.
A health plan can be profitable on an income-statement basis yet constrained by capital requirements during rapid growth. More premium and membership can require more statutory capital before the earnings arrive.
Regulatory Transactions and Interoperability
HIPAA Administrative Transactions
HIPAA administrative simplification rules establish standard electronic transaction formats, code sets, and operating expectations for common payer-provider exchanges. Core X12 transactions include enrollment, eligibility, claims, claim status, authorization, and remittance.
Using a standard format does not guarantee standardized business interpretation. Companion guides specify payer-specific requirements, and a syntactically valid transaction can still fail business validation.
270 and 271
The X12 270 transaction requests eligibility and benefit information. The 271 returns the response, potentially including coverage dates, plan details, cost sharing, service-type information, and limitations.
A successful 271 response is not a payment guarantee. It reports information available at the time and may not resolve authorization, medical necessity, coding, network, or retroactive eligibility issues.
276 and 277
The X12 276 requests claim-status information, while the 277 returns the response. These transactions help providers determine whether a claim was received, pended, finalized, or otherwise processed.
The 277 claim-status response should not be confused with the 277CA acknowledgment, which reports claim acceptance or rejection earlier in the submission process.
278
The X12 278 supports electronic requests and responses for healthcare services review, including prior authorization and referral workflows.
Implementation has historically varied, with portals, phone calls, and proprietary interfaces continuing alongside the standard. Current interoperability initiatives are pushing toward more structured electronic authorization, but translation between clinical documentation and administrative rules remains the difficult part.
FHIR and Da Vinci
Fast Healthcare Interoperability Resources, or FHIR, is a standard for exchanging healthcare information through modern application programming interfaces. The HL7 Da Vinci Project develops implementation guides for payer-provider use cases such as coverage discovery, documentation requirements, prior authorization, and payer data exchange.
FHIR defines how data can be represented and exchanged. It does not by itself reconcile benefit rules, provider contracts, or clinical criteria. An elegant API can deliver an ambiguous answer with impressive speed.
No Surprises Act, QPA, and IDR
The No Surprises Act restricts certain surprise bills and establishes protections for emergency services and specified services delivered by out-of-network providers at in-network facilities. The qualifying payment amount, or QPA, is generally based on a plan’s median contracted rate under statutory rules and informs member cost sharing and payment disputes.
The federal independent dispute resolution, or IDR, process allows eligible plans and providers to resolve certain out-of-network payment disputes after negotiation. It is distinct from a member appeal and does not simply compare the billed charge with the QPA.
Transparency in Coverage Machine-Readable Files
Transparency in Coverage rules require plans and issuers to publish large machine-readable files, or MRFs, containing negotiated rates and certain out-of-network allowed amounts. Public files commonly include extensive provider, billing-code, and rate combinations.
The data are technically rich but operationally difficult because of file size, identifier quality, contract complexity, and inconsistent rate expression. Finding a number is easier than proving it represents the comparable service, provider, and contract context.
ERISA Preemption
ERISA preemption limits the application of many state laws to private employer self-funded benefit plans, while preserving significant federal authority and certain state regulation of insurance. Fully insured products remain subject to state insurance regulation through the underlying policy.
Preemption is not a blanket statement that state law never applies. Provider regulation, general laws, stop-loss insurance, and other areas require separate analysis. When someone says, “ERISA preempts that,” the useful response is, “Which provision, and for which entity?”
Gag Clause Prohibition Compliance Attestation
The Consolidated Appropriations Act prohibits certain contractual clauses that restrict plans from accessing or sharing provider price and quality information. Plans and issuers submit a Gag Clause Prohibition Compliance Attestation, often shortened to GCPCA.
The obligation forces plans to examine network, TPA, PBM, and data-vendor agreements for restrictions that may be buried in confidentiality language. Signing the attestation is the final step; obtaining the contractual visibility is the actual work.
The Phrase Translator
“Eligibility is active, but the 834 never loaded.”
It may mean: The sponsor believes the person should be covered, but the health plan’s enrollment system has no successfully processed transaction. Claims and pharmacy systems are unlikely to recognize coverage until the record is corrected.
“It rejected at the front door; it was not denied.”
It may mean: The claim failed intake or validation and never reached full adjudication. Correct and resubmit it rather than launching a clinical appeal.
“PA is on file, but payment is not guaranteed.”
It may mean: The service passed an authorization checkpoint, but eligibility, coding, network status, benefit limits, and claim rules can still change the result.
“We have a TIN-level contract with an NPI-level load issue.”
It may mean: The provider organization is contracted, but the specific clinician, facility, location, or identifier is not correctly attached to the contract in the claims system.
“The claim priced off the wrap, not the direct contract.”
It may mean: A secondary rental network supplied the rate because the direct provider agreement was not found or did not apply. Expect questions about contract hierarchy and network-access fees.
“Admissions are flat, but DRG weight is up.”
It may mean: Inpatient volume has not increased, but case severity, coding intensity, or service mix is producing more expensive admissions.
“Offer a P2P before the appeal clock runs.”
It may mean: Give the treating clinician a chance to discuss the case with the reviewer, but do not assume that discussion pauses the formal appeal deadline.
“The gap is open administratively, but we may have chart evidence.”
It may mean: Claims or encounter data do not show the required service, although medical-record review or another approved clinical source may close the HEDIS gap.
“RAF is up, but normalize for model change and coding pattern.”
It may mean: The reported risk score increased, but the team must separate genuine morbidity changes from model coefficients, normalization, and documentation effects.
“The encounter cleared EDI and still rejected in EDPS.”
It may mean: The file passed basic transaction validation but failed Medicare Advantage encounter-processing rules later in the submission chain.
“The rebate guarantee is attractive; check the exclusions and spread.”
It may mean: The headline manufacturer-rebate commitment may be offset by formulary restrictions, excluded claims, pharmacy spread, specialty economics, or other retained revenue.
“We are below benchmark, but the rebate is already committed.”
It may mean: The Medicare Advantage bid creates rebate dollars, but those funds are needed to finance supplemental benefits, premium reductions, or lower member cost sharing.
“The metal level is right, but the CSR variant is wrong.”
It may mean: The member is enrolled in a Silver product, but not the correct cost-sharing-reduction version. Deductibles, copays, and accumulators may all require correction.
“IBNR moved because completion changed, not because experience improved.”
It may mean: The reserve estimate changed because the assumed claims-development pattern changed. Nobody should celebrate lower medical cost just yet.
“QPA is not billed charge, and IDR is not a claim appeal.”
It may mean: The No Surprises Act dispute concerns the eligible out-of-network payment methodology between plan and provider, not the provider’s sticker price or the member’s ordinary benefit appeal.
“The provider is gold carded, but this code is not.”
It may mean: The prior authorization exemption applies only to specified services, identifiers, products, or time periods. The provider’s general status does not eliminate every authorization requirement.
Net Net
Health payor language is difficult because benefit design, clinical review, claims logic, provider contracting, actuarial estimation, pharmacy economics, and regulation all describe the same episode from different angles. A familiar word such as allowed, risk, encounter, or member can carry a precise system or contractual meaning.
- Which legal entity is involved, and is it bearing risk, administering an ASO plan, or acting under delegated authority?
- Which product, funding arrangement, benefit package, and eligibility span applied on the date of service?
- Is this fundamentally an eligibility, benefit, authorization, coding, pricing, network, or payment issue?
- Are we discussing a claim or an encounter, and is it rejected, pended, denied, adjusted, or fully adjudicated?
- Which provider identifier controls here: billing NPI, rendering NPI, TIN, facility, location, or contract record?
- What determines the allowed amount: fee schedule, DRG, APC, per diem, case rate, capitation, QPA, or another methodology?
- Which document or rule controls: EOC, SPD, provider agreement, government contract, clinical policy, state mandate, or federal requirement?
- What is the metric’s denominator and time basis: member, employee, member month, paid date, incurred date, measurement year, or reporting year?
- Which risk-adjustment program, model version, data year, and submission pathway are being referenced?
- What evidence supports the conclusion: transaction response, claim detail, medical record, authorization record, contract term, or regulatory notice?
- Which specialist function has decision authority, such as claims, medical management, pharmacy, network contracting, actuarial, or regulatory affairs?
- What deadline or next transaction matters: corrected claim, P2P, appeal, external review, encounter resubmission, or reconciliation?
Real fluency does not require memorizing every acronym. It requires recognizing which specialized language changes coverage, payment, clinical access, regulatory responsibility, or plan economics, then asking the question that exposes the controlling rule.